Aclaris Therapeutics, Inc. - ACRS

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 17
Latest filed: Nov 05, 2026
Form Count
8-K 7
4 7
SCHEDULE 13G/A 2
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Nov 05, 2026 8-K Nov 05, 2026 0001104659-26-123039 View
Oct 27, 2026 8-K Oct 27, 2026 0001104659-26-119231 View
Oct 27, 2026 8-K Oct 27, 2026 0001104659-26-118952 View
Sep 21, 2026 SCHEDULE 13G — 0001231919-26-001199 View
Aug 14, 2026 SCHEDULE 13G/A — 0001231919-26-000915 View
Aug 06, 2026 8-K Aug 06, 2026 0001104659-26-092128 View
Aug 06, 2026 8-K Aug 06, 2026 0001104659-26-091629 View
Aug 04, 2026 4 Aug 01, 2026 0002076327-26-000006 View
Jun 08, 2026 4 Jun 04, 2026 0001280044-26-000004 View
Jun 08, 2026 4 Jun 04, 2026 0001187159-26-000002 View
Jun 08, 2026 4 Jun 04, 2026 0001674278-26-000002 View
Jun 08, 2026 4 Jun 04, 2026 0001172252-26-000002 View
Jun 08, 2026 4 Jun 04, 2026 0001590102-26-000002 View
Jun 08, 2026 4 Jun 04, 2026 0001654773-26-000003 View
Jun 04, 2026 8-K Jun 04, 2026 0001104659-26-070494 View
May 12, 2026 SCHEDULE 13G/A — 0001213900-26-055376 View
May 07, 2026 8-K May 07, 2026 0001104659-26-056669 View